Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]
-
Published:2021-07
Issue:
Volume:Volume 13
Page:645-646
-
ISSN:1178-6981
-
Container-title:ClinicoEconomics and Outcomes Research
-
language:en
-
Short-container-title:CEOR
Author:
Mareque Maria,
Montesinos Pau,
Font Patricia,
Guinea José MaríaORCID,
de la Fuente Adolfo,
Soto JavierORCID,
Oyagüez ItziarORCID,
Brockbank JamesORCID,
Iglesias Tamara,
Llinares Julia,
Sierra Jorge
Publisher
Informa UK Limited
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)